Chicago Equity Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-6,500
| Closed | -$243K | – | 853 |
|
|
2018
Q2 | $243K | Buy |
+6,500
| New | +$243K | 0.01% | 770 |
|
|
2014
Q3 | – | Sell |
-202,715
| Closed | -$7.89M | – | 482 |
|
|
2014
Q2 | $7.89M | Buy |
202,715
+12,245
| +6% | +$477K | 0.21% | 125 |
|
|
2014
Q1 | $6.51M | Buy |
190,470
+152,525
| +402% | +$5.21M | 0.18% | 144 |
|
|
2013
Q4 | $796K | Sell |
37,945
-43,300
| -53% | -$908K | 0.02% | 276 |
|
|
2013
Q3 | $1.91M | Buy |
81,245
+8,315
| +11% | +$195K | 0.06% | 229 |
|
|
2013
Q2 | $1.96M | Buy |
+72,930
| New | +$1.96M | 0.06% | 217 |
|